Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Societies & Institutes
Databases & Libraries
Other links

Prostate Disease

Volume 20, Issue 5 (Sep 2018)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
Yasutaka Yamada1,2, Shinichi Sakamoto2, Yoshiyasu Amiya1, Makoto Sasaki1, Takayuki Shima1, Akira Komiya2, Noriyuki Suzuki1, Koichiro Akakura3, Tomohiko Ichikawa2, Hiroomi Nakatsu1
Asian J Androl 20: 432-437; 10.4103/aja.aja_24_18
Abstract |Full TextPDF PDF

Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment
Chang Liu1, Shi-Liang Liu1, Zhi-Xian Wang1, Kai Yu1, Chun-Xiang Feng1, Zan Ke2, Liang Wang2, Xiao-Yong Zeng1
Asian J Androl 20: 459-464; 10.4103/aja.aja_19_18
Abstract |Full TextPDF PDF

The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2
Ying Zhang1, Li-Na Wang2, Ya-Ni Lin1, Yuan-Xin Xing1, Yu Shi3, Jian Zhao4, Wei-Wen Chen1, Bo Han5
Asian J Androl 20: 511-517; 10.4103/aja.aja_36_18
Abstract |Full TextPDF PDF

Volume 20, Issue 4 (Jul 2018)
Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
Yi-Shuo Wu1,2, Xiao-Bo Wu1,2, Ning Zhang1,2, Guang-Liang Jiang1,2, Yang Yu1, Shi-Jun Tong1,2, Hao-Wen Jiang1,2, Shan-Hua Mao1,2, Rong Na2,3, Qiang Ding1,2
Asian J Androl 20: 324-329; 10.4103/aja.aja_81_17
Abstract |Full TextPDF PDF

The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer
Cheng Chen1, Ye Chen2, Lin-Kun Hu3, Chang-Chuan Jiang4, Ren-Fang Xu1, Xiao-Zhou He1
Asian J Androl 20: 366-371; 10.4103/aja.aja_5_18
Abstract |Full TextPDF PDF

Hormone levels following surgical and medical castration: defining optimal androgen suppression
Michael T Schweizer1,2, Michael L Hancock, Robert H Getzenberg3, Evan Y Yu1,2
Asian J Androl 20: 405-406; 10.4103/aja.aja_38_17
Full TextPDF PDF

The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects
Zhuang Tang1,2, Xiao-Mei Wu3, Qiang Wei1,2, Lin-Na Wu3
Asian J Androl 20: 417-419; 10.4103/aja.aja_41_17
Full TextPDF PDF

Volume 20, Issue 3 (May 2018)
The path forward in prostate cancer therapeutics
Jeanny B Aragon-Ching1, Ravi A Madan2
Asian J Androl 20: 213-214; DOI: 10.4103/aja.aja_3_18
Full TextPDF PDF

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
Tanya B Dorff1, Neeraj Agarwal2
Asian J Androl 20: 215-220; 10.4103/aja.aja_12_18
Abstract |Full TextPDF PDF

Role of chemotherapy in prostate cancer
Rita Nader1, Joelle El Amm2, Jeanny B Aragon-Ching3
Asian J Androl 20: 221-229; 10.4103/aja.aja_40_17
Abstract |Full TextPDF PDF

[首页] [前一页][后一页] [尾页]  共有48页,10条记录

Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved